Short answer
AVANOS MEDICAL, INC. (AVNS) filed an 8-K current report with the SEC on April 14, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Acquisition agreement announced April 13, 2026; shareholders to receive $25.00 cash per share.
AVANOS MEDICAL, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Acquisition agreement announced April 13, 2026; shareholders to receive $25.00 cash per share
- Avanos becomes a wholly owned subsidiary of A-AV Holdco following merger completion
- Closing requires majority shareholder approval, antitrust clearances, and no Material Adverse Effect
- Transaction target date January 13, 2027, with no financing condition
- $37.5 million termination fee creates a meaningful deterrent to superior competing offers
Item 7.01 · Regulation FD Disclosure
- Proposed merger requires SEC-filed Schedule 14A proxy statement before shareholder consideration
- Definitive proxy materials will detail transaction terms, voting matters, and potential management conflicts
- Avanos directors, executives, and employees may solicit shareholder proxies as transaction participants
- Investors should review the proxy statement and amendments before voting on the proposed merger
Item EX-99.1 · Exhibit EX-99.1
- AIP agreed to acquire Avanos for approximately $1.272 billion enterprise value in an all-cash transaction
- Avanos stockholders will receive $25.00 per share, a 72.1% premium to April 13’s closing price
- Consideration also represents an 82.8% premium to Avanos’ 30-day volume-weighted average share price
- Closing expected in the second half of 2026, subject to stockholder, antitrust and other regulatory approvals
- Avanos will become private and delist from the NYSE; transaction carries execution risk until completion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AVANOS MEDICAL, INC. 8-K filings
Get the next AVNS 8-K as it lands
Follow AVNS for push alerts, or ask the research agent what this filing means.